1-3 of 3
Francesca Binda, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group

Giuseppe Rossi, MD, Francesca Paoloni, Bruno Fattizzo, MD, Francesca Binda, MD, Mariella D'Adda, MD, Mirko Farina, MD, Cecilia Carbone, MD, Francesco Zaja, MD, Elisa Lucchini, MD, Francesca Romana Mauro, MD, Flavia Salvi, MD, Monia Marchetti, MD, Paola Fazi, Wilma Barcellini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2199.
https://doi.org/10.1182/blood.V130.Suppl_1.2199.2199
Published: 2017
Journal Articles

Immune Thrombocytopenia Associated to Low-Dose Alemtuzumab Therapy in Chronic Lymphocytic Leukemia: A Single Retrospective Center Experience

Gianluigi Reda, MD, Francesco Maura, MD, Giuseppe Gritti, MD, Daniele Vincenti, MD, Mariarita Sciumé, MD, Nicola Orofino, MD, Anna Ines Gregorini, MD, Cristina Bucelli, MD, Francesca Binda, MD, Francesca Guidotti, MD, Alfonso Piciocchi, Francesco Rodeghiero, MD, Antonino Neri, Agostino Cortelezzi, MD
Journal: Blood
Blood (2012) 120 (21): 4598.
https://doi.org/10.1182/blood.V120.21.4598.4598
Published: 2012
Journal Articles

5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience

Alessandra Freyrie, MD, Gianluigi Reda, MD, Daniele Vincenti, MD, Mariarita Sciumé, MD, Francesca Binda, MD, Francesca Guidotti, MD, Agostino Cortelezzi, MD
Journal: Blood
Blood (2012) 120 (21): 4963.
https://doi.org/10.1182/blood.V120.21.4963.4963
Published: 2012